DEFA14A: INmune Bio Inc. Corrects Typographical Error in Proxy Statement Regarding Stock Incentive Plan Voting Standard

INmune Bio Inc. files a supplement to its proxy statement to correct a typographical error concerning the voting standard for the approval of the Second Amended and Restated 2021 Stock Incentive Plan.

Summary

• INmune Bio Inc. has filed a supplement to its proxy statement for the Annual Meeting of Stockholders to be held on May 28, 2025.
• The supplement corrects a typographical error related to the voting standard for Proposal 5, which concerns the approval of the Second Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan.
• The original proxy statement incorrectly stated that Proposal 5 required the affirmative vote of a majority of the shares present in person or by proxy.
• The corrected language specifies that Proposal 5 requires the affirmative vote of the majority of shares cast on the proposal.
• The supplement also clarifies that abstentions and broker non-votes will count towards the quorum requirement but will not be counted as a vote for or against Proposal 5.
• The correction does not affect the voting standards for Proposals 1, 2, 3, or 4, which were correctly stated in the original proxy statement.
• The proposals to be acted upon at the Annual Meeting remain unchanged.

Sentiment

Score: 7

Explanation: The document is a neutral correction of a minor error. It reflects positively on the company's attention to detail and commitment to accurate communication.

Positives

• The company is proactively addressing and correcting an error in its proxy statement, ensuring accurate information is provided to stockholders.

Future Outlook

The supplement does not change the proposals to be acted upon at the Annual Meeting, which are described in the Proxy Statement.

Industry Context

This announcement is a routine correction to a proxy statement, a common occurrence in corporate governance. It does not indicate any broader industry trends or competitive pressures.

Stakeholder Impact

• The correction ensures that stockholders have accurate information regarding the voting standard for Proposal 5, which is important for informed decision-making.

Key Dates

Keywords

Proxy Statement, INmune Bio, Stock Incentive Plan, Voting Standard, Annual Meeting, Correction